Drug interactions
Buprenorphine subdermal implant + Tapentadol
Severity: Major
Buprenorphine subdermal implant and Tapentadol: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Buprenorphine from the implant is a high-affinity partial agonist that can reduce tapentadol analgesia or precipitate withdrawal in opioid-dependent patients. Where both are active, sedation and respiratory depression may be additive.
What this interaction means in plain words
Buprenorphine subdermal implant and Tapentadol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Competitive binding at mu receptors by a partial agonist, plus additive CNS depression.
What to do
Avoid adding tapentadol in patients with a buprenorphine implant unless specialist-supervised. Monitor for withdrawal, poor pain control and respiratory depression.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Tapentadol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Tapentadol
- Calcium / magnesium / potassium / sodium oxybates + Tapentadol Contraindicated
- Isocarboxazid + Tapentadol Contraindicated
- Linezolid + Tapentadol Contraindicated
- Methylene blue + Tapentadol Contraindicated
- Olanzapine / samidorphan + Tapentadol Contraindicated
- Phenelzine + Tapentadol Contraindicated
Frequently asked questions
Can I take Buprenorphine subdermal implant with Tapentadol?
MediHelp rates the interaction as major. Buprenorphine subdermal implant and Tapentadol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Buprenorphine from the implant is a high-affinity partial agonist that can reduce tapentadol analgesia or precipitate withdrawal in opioid-dependent patients. Where both are active, sedation and respiratory depression may be additive.
How serious is the interaction between Buprenorphine subdermal implant and Tapentadol?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid adding tapentadol in patients with a buprenorphine implant unless specialist-supervised. Monitor for withdrawal, poor pain control and respiratory depression.
What other medicines interact with Tapentadol?
MediHelp also lists interactions of Tapentadol with, for example, Calcium / magnesium / potassium / sodium oxybates, Isocarboxazid, Linezolid. The full list is on the Tapentadol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
